glp 1 help with autoimmune disease GLP-1-based meds linked to fewer heart events in adults obesity, GLP-1 medicines may cut clot-related
Description
In this study, we have identified G protein-coupled receptor 55 (GPR55) as a target of curcumin
Drucker DJ, Sherman SI, Bergenstal RM, Buse JB
The widespread adoption of GLP-1 receptor agonists, including semaglutide (Ozempic/Wegovy) and liraglutide (Victoza), for diabetes and obesity treatment has fueled immense global demand
Its the same scale that was used in the trials for Leqembi and Kisunla, two drugs that aim to slow the progression of the disease by clearing clumps of protein called amyloid plaques from the brain
Simple steps can manage most side effects
doi: 10.1038/ijo.2013.149
